Schedule of Comparison of Basic and Fully Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Earnings Per Share [Abstract]
Net loss - before noncontrolling interest	$ (12,670)	$ (5,844)	$ (22,779)	$ (20,755)
Net loss attributable to noncontrolling interest	1,199	266	1,877	702
Net loss - as reported, attributable to PAVmed Inc.	(11,471)	(5,578)	(20,902)	(20,053)
Series B Convertible Preferred Stock dividends:	(74)	(71)	(149)	(141)
Net loss attributable to PAVmed Inc. common stockholders	$ (11,545)	$ (5,649)	$ (21,051)	$ (20,194)
Weighted average common shares outstanding, basic and diluted	82,235,397	44,780,538	78,117,637	44,140,126
Net loss - as reported, attributable to PAVmed Inc.	$ (0.14)	$ (0.12)	$ (0.27)	$ (0.45)
Net loss attributable to PAVmed Inc. common stockholders	$ (0.14)	$ (0.13)	$ (0.27)	$ (0.46)